We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RSPI RespireRx Pharmaceuticals Inc (PK)

-0.0001 (-8.33%)
Feb 29 2024 - Closed
Delayed by 15 minutes

RespireRx Pharmaceuticals (PK) Financial Summary

The current RSPI market cap is 401.96k. The company's latest EPS is USD -0.0109 and P/E is 0.00.

Year End December 30 2022 20182019202020212022
Total Revenue 00000
Operating Income -2.18M-1.74M-3.32M-2.56M-1.58M
Net Income -2.59M-2.12M-5.74M-3.52M-3.97M
Year End December 30 2022 20182019202020212022
Total Assets 124k45k85k209k23k
Total Liabilities 5.86M7.49M8.15M10.22M11.9M
Total Equity -5.73M-7.45M-8.06M-10.01M-11.88M

Cash Flow

Year End December 30 2022 20182019202020212022
Operating -428k-487k-513k-956k-144k
Investing N/A N/A N/A N/A N/A
Financing 376k471k497k956k143k
Market Cap 401.96k
Price to Earnings Ratio 0.00
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 365.42M
Average Volume (1 week) 9.53M
Average Volume (1 Month) 13.06M
52 Week Change -68.57%
52 Week High 0.0191
52 Week Low 0.0006
Spread (Intraday) 0 (16.67%)

Company Info

Company Name RespireRx Pharmaceuticals Inc (PK)
Address 900 foulk road
wilmington, delaware 19803
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |